Semalytix Blog Pharma companies should include social media analysis in their RWE portfolio - here’s why

Pharmaceutical companies investing in real-world evidence (RWE) to support R&D are reaping the rewards, according to a recent study by Deloitte1. The benefits of using RWE have steadily expanded from commercial settings into development, approval and reimbursement. Today, compelling RWE can be critical in determining product success or failure.